541 related articles for article (PubMed ID: 7850799)
1. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG
Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799
[TBL] [Abstract][Full Text] [Related]
2. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid.
Delia D; Aiello A; Lombardi L; Pelicci PG; Grignani F; Grignani F; Formelli F; Menard S; Costa A; Veronesi U
Cancer Res; 1993 Dec; 53(24):6036-41. PubMed ID: 8261419
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of retinoic acid (RA) and N-(4-hydroxyphenyl) retinamide (4-HPR) on cell growth, induction of differentiation, and changes in p34cdc2, Bcl-2, and actin expression in the human promyelocytic HL-60 leukemic cells.
Dipietrantonio A; Hsieh TC; Wu JM
Biochem Biophys Res Commun; 1996 Jul; 224(3):837-42. PubMed ID: 8713132
[TBL] [Abstract][Full Text] [Related]
4. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
[TBL] [Abstract][Full Text] [Related]
5. Differential induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl)retinamide in human head and neck squamous cell carcinoma cell lines.
Oridate N; Lotan D; Xu XC; Hong WK; Lotan R
Clin Cancer Res; 1996 May; 2(5):855-63. PubMed ID: 9816241
[TBL] [Abstract][Full Text] [Related]
6. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
[TBL] [Abstract][Full Text] [Related]
7. The effects of retinoic acid on the in vitro and in vivo growth of neuroblastoma cells.
Abemayor E
Laryngoscope; 1992 Oct; 102(10):1133-49. PubMed ID: 1328787
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression.
Xu H; Cheepala S; McCauley E; Coombes K; Xiao L; Fischer SM; Clifford JL
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):969-79. PubMed ID: 16467112
[TBL] [Abstract][Full Text] [Related]
9. N-(4-hydroxyphenyl)retinamide (Fenretinide) in combination with retinoic acid enhances differentiation and retinoylation of proteins.
Takahashi N; Sausville EA; Breitman TR
Clin Cancer Res; 1995 Jun; 1(6):637-42. PubMed ID: 9816026
[TBL] [Abstract][Full Text] [Related]
10. Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites.
Sabichi AL; Xu H; Fischer S; Zou C; Yang X; Steele VE; Kelloff GJ; Lotan R; Clifford JL
Clin Cancer Res; 2003 Oct; 9(12):4606-13. PubMed ID: 14555536
[TBL] [Abstract][Full Text] [Related]
11. The anti-tumor agent, p-DDAP potently suppresses proliferation through apoptosis in human neuroblastoma NB-39-nu cells.
Takahashi N; Egawa R; Imai M; Takahashi K; Ohba T; Imaizumi M
Cancer Lett; 2010 Nov; 297(2):252-8. PubMed ID: 20580487
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells.
Shan D; Gopal AK; Press OW
Clin Cancer Res; 2001 Aug; 7(8):2490-5. PubMed ID: 11489831
[TBL] [Abstract][Full Text] [Related]
13. Carcinoma cell lines resistant for growth inhibition and apoptosis to retinoic acid are responsive to 4-hydroxy-phenyl-retinamide: correlation with tissue transglutaminase.
Chiantore MV; Giandomenico V; De Luca LM
Biochem Biophys Res Commun; 1999 Jan; 254(3):636-41. PubMed ID: 9920792
[TBL] [Abstract][Full Text] [Related]
14. The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide.
Armstrong JL; Martin S; Illingworth NA; Jamieson D; Neilson A; Lovat PE; Redfern CP; Veal GJ
Oncol Rep; 2012 Jan; 27(1):293-8. PubMed ID: 21964808
[TBL] [Abstract][Full Text] [Related]
15. Fenretinide: induction of apoptosis and endogenous transforming growth factor beta in PC-3 prostate cancer cells.
Roberson KM; Penland SN; Padilla GM; Selvan RS; Kim CS; Fine RL; Robertson CN
Cell Growth Differ; 1997 Jan; 8(1):101-11. PubMed ID: 8993839
[TBL] [Abstract][Full Text] [Related]
16. Higher potency of N-(4-hydroxyphenyl)retinamide than all-trans-retinoic acid in induction of apoptosis in non-small cell lung cancer cell lines.
Zou CP; Kurie JM; Lotan D; Zou CC; Hong WK; Lotan R
Clin Cancer Res; 1998 May; 4(5):1345-55. PubMed ID: 9607596
[TBL] [Abstract][Full Text] [Related]
17. Neuroblastoma cell apoptosis induced by the synthetic retinoid N-(4-hydroxyphenyl)retinamide.
Di Vinci A; Geido E; Infusini E; Giaretti W
Int J Cancer; 1994 Nov; 59(3):422-6. PubMed ID: 7927952
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance.
Lasorella A; Iavarone A; Israel MA
Cancer Res; 1995 Oct; 55(20):4711-6. PubMed ID: 7553653
[TBL] [Abstract][Full Text] [Related]
19. Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells.
Taetle R; Dos Santos B; Akamatsu K; Koishihara Y; Ohsugi Y
Clin Cancer Res; 1996 Feb; 2(2):253-9. PubMed ID: 9816167
[TBL] [Abstract][Full Text] [Related]
20. Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells.
Wainwright LJ; Lasorella A; Iavarone A
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9396-400. PubMed ID: 11481496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
